What's happening
This bill allows licensed pharmacists in New York to order and administer FDA-approved infectious disease tests at pharmacies.
Why it matters
Expands convenient access to infectious disease testing. by allowing pharmacists—who are widely available in communities—to order and perform FDA-approved tests, making it easier for people to get tested without visiting a doctor’s office or clinic.
Empowers pharmacists as frontline healthcare providers. , recognizing them as qualified professionals to direct limited service laboratories for infectious disease testing, which could help relieve pressure on other healthcare settings, especially during outbreaks.
Potentially speeds up detection and response to infectious diseases. by enabling quicker testing and results in pharmacies, which may help with earlier diagnosis, treatment, and containment of diseases in the community.
Imposes training and regulatory safeguards. , requiring pharmacists to complete department-developed training and comply with federal waiver requirements, aiming to ensure the safety and accuracy of testing conducted outside traditional labs.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Let Pharmacists Test Diseases
Plain English, a few words. Used as the page title.
Sponsors
Senator · Senate District 42
3 Co-sponsors
History
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Let Pharmacists Test Diseases
In Assembly Committee · Higher Education · Sponsor Anna Kelles
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
5263
2023-2024 Regular Sessions
IN SENATE
February 28, 2023
Introduced by Sens. SKOUFIS, ADDABBO, HOYLMAN-SIGAL, LIU -- read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the public health law, in relation to allowing for the testing of certain infectious diseases at pharmacies
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Section 579 of the public health law is amended by adding a new subdivision 4 to read as follows:
4. (a) Any licensed pharmacists may order infectious disease tests, approved by the food and drug administration, to detect the infectious disease or its antibodies, and administering such tests, subject to certificate of waiver requirements pursuant to the federal clinical laboratory improvement act of nineteen hundred eighty-eight, to patients suspected of an infectious disease, or suspected of having recovered from an infectious disease, subject to completion of appropriate training developed by the department.
(b) Licensed pharmacists shall be designated as a qualified healthcare professional for the purpose of directing a limited service laboratory, pursuant to subdivision three of this section, to test patients suspected of an infectious disease or its antibodies provided that such test is approved by the food and drug administration and waived for its use in a limited service laboratory.
§ 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD05223-01-3
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to allowing for the testing of certain infectious diseases at pharmacies
Purpose
To permit licensed pharmacists to order and administer infectious diseases tests approved by the FDA.
Summary of provisions
Section 1: Amends Section 579 of the Public Health Law by adding subdi- vision 4, to permit licensed pharmacists to order and administer tests to patients suspected of an infectious disease or its antibodies, provided such test is approved by the Food and Drug Administration (FDA). Requires certification of waiver requirements pursuant to the Federal Clinical Laboratory Improvement Act of 1988 and requires such pharmacists complete appropriate training developed by the FDA. Desig- nates licensed pharmacists as qualified healthcare professionals for the purpose of directing a limited service laboratory, for the purpose of testing patients, provided such test is approved by the FDA and waived for its use in a limited service laboratory.
Section 2: Sets effective date.
Justification
As was evident with the initial spread of COVID-19 in New York State, the demands placed upon hospitals and healthcare providers are often overwhelming. Even without a declared state of emergency, the high demands on hospitals and healthcare providers continues. Permitting licensed pharmacists to order and administer such tests will lessen the burden placed on our hospitals by freeing up physicians, nurses and other healthcare providers to actively provide patient care, allowing for the more efficient treatment of patients.
Legislative history
Senate
2020 - S8570, Referred to Rules
2021-2022- S1742, Referred to Health
Assembly
2020- A10699, Referred to Higher Education
2021-2022- A1534, Referred to Higher Education
Fiscal implications
None.
Effective date
This act shall take effect immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.